Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Ascendis Pharma A/S
USWM, LLC (dba US WorldMeds)
University of Washington
Incyte Corporation
University Health Network, Toronto
ARCAGY/ GINECO GROUP
National Cancer Institute (NCI)
Carisma Therapeutics Inc
NextCure, Inc.
Revolution Medicines, Inc.
Salubris Biotherapeutics Inc
Adaptimmune